PMC7145984_01
Selected laboratory values observed during the early stages of the disease and the timing of plasma exchange, hemodialysis and administration of eculizumab. In panel (A) is represented the development of blood hemoglobin measurements, in panel (B) the serum creatinine level, in panel (C) the number of platelets, and in panel (D) D-dimer of fibrin values across the 17 day follow-up period.
fimmu-11-00548-g0002.jpg
PMC7145984_01_fimmu-11-00548-g0002.jpg
F2
She did not require further hemodialysis after her third hemodialysis on the sixth postpartum day (Figure 2).